Literature DB >> 11165196

Urinary excretion of apolipoprotein(a): relation to other plasma proteins.

K Kostner1, S Spitzauer, H Rumpold, G Maurer, G Knipping, A Hrzenjak, S Frank, G M Kostner.   

Abstract

The atherogenic lipoprotein Lp(a) consists of an LDL-like core and apo(a), linked to apoB via a thiol bridge. Apo(a) fragments ranging in size from 60 to 220 kDa are excreted into urine and the excretion rate correlates significantly with the plasma levels of Lp(a). In order to study the interrelationship of apo(a) secretion with that of other plasma proteins, urinary apo(a) and protein secretion of five probands were followed for 24 h at different urinary densities. The excretion rate of apo(a) fragments, despite their high molecular weight, was highest, followed by apoD, orosomucoid, albumin and beta(2)-glycoprotein-I (beta2-GI) and plasminogen (1.58, 0.87, 0.095, 0.027, 0.013 and <0.001%/day, respectively). There was a highly significant correlation between apo(a), apoD and beta2-GI concentrations but not with albumin and orosomucoid concentrations in urine. The only protein that was fragmented in urine was apo(a) while the other proteins had molecular weights comparable to those in plasma. We conclude that a previously suggested fragmentation of apo(a) by the kidney is not a rate-limiting step in its excretion. Since plasminogen, another kringle-IV-containing plasma compound, and fragments thereof, are undetectable in urine under identical experimental conditions, it is very unlikely that the characteristic kringle structure is responsible for the high excretion rate of apo(a).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11165196     DOI: 10.1016/s0009-8981(00)00394-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

Review 1.  Lipoprotein(a) metabolism: potential sites for therapeutic targets.

Authors:  Jane Hoover-Plow; Menggui Huang
Journal:  Metabolism       Date:  2012-10-04       Impact factor: 8.694

2.  Metabolic disease and ABHD6 alter the circulating bis(monoacylglycerol)phosphate profile in mice and humans.

Authors:  Gernot F Grabner; Nermeen Fawzy; Maria A Pribasnig; Markus Trieb; Ulrike Taschler; Michael Holzer; Martina Schweiger; Heimo Wolinski; Dagmar Kolb; Angela Horvath; Rolf Breinbauer; Thomas Rülicke; Roland Rabl; Achim Lass; Vanessa Stadlbauer; Birgit Hutter-Paier; Rudolf E Stauber; Peter Fickert; Rudolf Zechner; Gunther Marsche; Thomas O Eichmann; Robert Zimmermann
Journal:  J Lipid Res       Date:  2019-03-20       Impact factor: 5.922

3.  Association between high molecular weight apolipoprotein isoforms and lipoprotein levels in advanced chronic kidney disease and the effect of hemodialysis.

Authors:  J K Gambhir; O P Kalra; A Khaira; H Kaur
Journal:  Indian J Nephrol       Date:  2013-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.